Authors:
BONAGURA VR
AGOSTINO N
BORRETZEN M
THOMPSON KM
NATVIG JB
MORRISON SL
Citation: Vr. Bonagura et al., MAPPING IGG EPITOPES BOUND BY RHEUMATOID FACTORS FROM IMMUNIZED CONTROLS IDENTIFIES DISEASE-SPECIFIC RHEUMATOID FACTORS PRODUCED BY PATIENTS WITH RHEUMATOID-ARTHRITIS, The Journal of immunology, 160(5), 1998, pp. 2496-2505
Authors:
ALAGIB KEE
BORRETZEN M
JONSSON R
HAGA HJ
THOEN J
THOMPSON KM
NATVIG JB
Citation: Kee. Alagib et al., STRUCTURAL COMPARISON OF RHEUMATOID FACTORS (RF) FROM PATIENTS WITH PRIMARY SJOGRENS-SYNDROME (PSS), RHEUMATOID-ARTHRITIS (RA) AND HEALTHY IMMUNIZED DONORS (HID), Arthritis and rheumatism, 41(9), 1998, pp. 307-307
Citation: M. Borretzen et al., HETEROGENEOUS RF STRUCTURES BETWEEN AND WITHIN HEALTHY-INDIVIDUALS ARE NOT RELATED TO HLA DRB1-ASTERISK-0401, Molecular immunology, 34(12-13), 1997, pp. 929-938
Authors:
BORRETZEN M
CHAPMAN C
NATVIG JB
THOMPSON KM
Citation: M. Borretzen et al., DIFFERENCES IN MUTATIONAL PATTERNS BETWEEN RHEUMATOID FACTORS IN HEALTH AND DISEASE ARE RELATED TO VARIABLE HEAVY-CHAIN FAMILY AND GERM-LINE GENE USAGE, European Journal of Immunology, 27(3), 1997, pp. 735-741
Authors:
TRAN H
LIU YJ
ARPIN C
BANCHEREAU J
THOMPSON KM
BORRETZEN M
NATVIG JB
Citation: H. Tran et al., SUBSETS OF GERMINAL CENTER (GC) LIKE B-CELLS IN SYNOVIAL TISSUES (ST)FROM PATIENTS WITH RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 40(9), 1997, pp. 1282-1282
Authors:
BORRETZEN M
CHAPMAN C
STEVENSON FK
NATVIG JB
THOMPSON KM
Citation: M. Borretzen et al., STRUCTURAL-ANALYSIS OF V(H)4-21 ENCODED HUMAN-IGM ALLOANTIBODIES AND AUTOANTIBODIES AGAINST RED-BLOOD-CELLS, Scandinavian journal of immunology, 42(1), 1995, pp. 90-97
Authors:
BORRETZEN M
RANDEN I
NATVIG JB
THOMPSON KM
Citation: M. Borretzen et al., STRUCTURAL RESTRICTION IN THE HEAVY-CHAIN CDR3 OF HUMAN RHEUMATOID FACTORS, The Journal of immunology, 155(7), 1995, pp. 3630-3637
Authors:
BONAGURA VR
AGOSTINO N
KWONG T
BORRETZEN M
THOMPSON KM
NATVIG J
MORRISON SL
Citation: Vr. Bonagura et al., HEALTHY IMMUNIZED DONORS (HLDS) AND RHEUMATOID-ARTHRITIS PATIENTS PRODUCE IGM RHEUMATOID FACTORS (RF) THAT REACT DIFFERENTLY WITH GENETICALLY-ENGINEERED, CHIMERIC IGG ANTIBODIES (CLGG), Arthritis and rheumatism, 38(9), 1995, pp. 83-83
Authors:
BORRETZEN M
RANDEN I
ZDARSKY E
FORRE O
NATVIG JB
THOMPSON KM
Citation: M. Borretzen et al., CONTROL OF AUTOANTIBODY AFFINITY BY SELECTION AGAINST AMINO-ACID REPLACEMENTS IN THE COMPLEMENTARITY-DETERMINING REGIONS, Proceedings of the National Academy of Sciences of the United Statesof America, 91(26), 1994, pp. 12917-12921
Authors:
THORPE SJ
BORRETZEN M
BAILEY SW
RANDEN I
NATVIG JB
THOMPSON KM
Citation: Sj. Thorpe et al., HUMAN MONOCLONAL RHEUMATOID FACTORS - INCIDENCE OF CROSS-REACTIONS WITH TISSUE-COMPONENTS AND CORRELATION WITH V-H GENE USAGE, Immunology, 83(1), 1994, pp. 114-121
Authors:
THOMPSON KM
RANDEN I
BORRETZEN M
FORRE O
NATVIG JB
Citation: Km. Thompson et al., VARIABLE REGION GENE USAGE OF HUMAN MONOCLONAL RHEUMATOID FACTORS DERIVED FROM HEALTHY DONORS FOLLOWING IMMUNIZATION, European Journal of Immunology, 24(8), 1994, pp. 1771-1778